¼¼°èÀÇ Â÷»ì¸®½Ç»ê ºñ½º¹«Æ® ½ÃÀå º¸°í¼­(2025³â)
Bismuth Subsalicylate Global Market Report 2025
»óǰÄÚµå : 1760487
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,217,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,987,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,756,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Â÷»ì¸®½Ç»ê ºñ½º¹«Æ® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 6.9%ÀÇ CAGR·Î 23¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¼ºÀå Àü¸ÁÀº À§Àå Àå¾Ö À¯º´·ü Áõ°¡, ÀϹÝÀǾàǰ(OTC) ¼ö¿ä Áõ°¡, ¼ÒÈ­±â °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¦¾à »ê¾÷ È®´ë, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄɾî ÀÎÇÁ¶ó °³¹ß µîÀÇ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Á¦»êÁ¦ ¹× ¸Þ½º²¨¿ò ¹æÁöÁ¦ÀÇ Àαâ, ¾×»ó ¹× Á¤Á¦ ÇüÅÂÀÇ Â÷»ì¸®½Ç»ê ºñ½º¹«Æ®ÀÇ °¡¿ë¼º, ȯÀÚ ¼øÀÀµµ¸¦ Çâ»ó½ÃŰ´Â Á¦Á¦ÀÇ ¹ßÀü, Á¦¾à»ç °£ÀÇ Àü·«Àû Á¦ÈÞ, Â÷»ì¸®½Ç»ê ºñ½º¹«Æ® ±â¹Ý ºê·£µå Á¦Á¦ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

À§Àå Àå¾ÖÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È Â÷»ì¸®½Ç»ê ºñ½º¹«Æ® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À§Àå Àå¾Ö´Â À§, Àå ¹× °ü·Ã ±â°üÀ» Æ÷ÇÔÇÑ ¼ÒÈ­°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç, Á¾Á¾ ÅëÁõ, º¹ºÎ ÆØ¸¸°¨, ¹èº¯ÀÇ º¯È­¿Í °°Àº Áõ»óÀ» À¯¹ßÇÕ´Ï´Ù. °¡°ø½ÄǰÀÇ °ú´Ù ¼·Ãë, ½ÄÀ̼¶À¯ ¼·Ãë ºÎÁ· µî ½Ä½À°ü Àå¾Ö´Â Àå³» ¼¼±ÕÃÑÀÇ ±ÕÇüÀ» ±ú¶ß¸®°í ¼ÒÈ­¸¦ ¹æÇØÇÏ¿© À§Àå Àå¾Ö¸¦ Áõ°¡½ÃŰ´Â ÁÖ¿ä ¿øÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. Â÷»ì¸®½Ç»ê ºñ½º¹«Æ®´Â Àå³» ¿°ÁõÀ» ¾ïÁ¦Çϰí À¯ÇØÇÑ ¹ÚÅ׸®¾ÆÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ¿© ¼³»ç¿Í °°Àº À§Àå Àå¾Ö¸¦ ¿ÏÈ­ÇÏ´Â µ¥ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î, ScienceDirect°¡ 2025³â 5¿ù¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, 2022³â¿¡´Â ¾à 2,350¸¸ °ÇÀÇ À§Àå ³»½Ã°æ °Ë»ç°¡ ½Ç½ÃµÇ¾î Àü³â ´ëºñ 6% Áõ°¡ÇÏ¿´´Ù°í ÇÕ´Ï´Ù. ±× °á°ú, ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ Â÷»ì¸®½Ç»ê ºñ½º¹«Æ®ÀÇ ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦¾à »ê¾÷ÀÇ ¼ºÀåÀº Â÷»ì¸®½Ç»ê ºñ½º¹«Æ® ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾à »ê¾÷Àº °Ç°­ ÁõÁø ¹× ´Ù¾çÇÑ Áúº´À» Ä¡·áÇϱâ À§ÇÑ ÀǾàǰ ¹× Ä¡·á Á¦Ç°ÀÇ ¿¬±¸ °³¹ß, Á¦Á¶ ¹× ¸¶ÄÉÆÃ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÌ Àü ¼¼°èÀûÀ¸·Î È®»êµÊ¿¡ µû¶ó Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¦¾à ºÐ¾ßÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È®ÀåÀº Â÷»ì¸®½Ç»ê ºñ½º¹«Æ®ÀÇ °í±Þ Á¦Çü°ú À¯Åë ä³ÎÀÇ È®´ë·Î À§Àå Àå¾Ö Ä¡·áÁ¦·Î¼­ Àü ¼¼°èÀûÀ¸·Î ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ±¹Á¦Á¦¾àÇùȸ(IFPMA)°¡ 2024³â 11¿ù¿¡ º¸°íÇÑ ¹Ù¿¡ µû¸£¸é, Á¦¾à»ê¾÷Àº 2022³â ¼¼°è GDP¿¡ 2Á¶ 2,950¾ï ´Þ·¯ÀÇ ±â¿©¸¦ ÇÒ °ÍÀ̸ç, ±× Áß Á÷Á¢ ±â¿©ºÐÀº 7,550¾ï ´Þ·¯·Î ¼¼°è GDPÀÇ 0.7%¿¡ ÇØ´çÇÕ´Ï´Ù. Á¦¾à »ê¾÷ÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀº Â÷»ì¸®½Ç»ê ºñ½º¹«Æ®ÀÇ °³¹ß ¹× À¯ÅëÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Bismuth subsalicylate is an over-the-counter medication that alleviates digestive symptoms by coating the stomach lining to protect it from acid, reducing inflammation, and exhibiting mild antibacterial properties. It helps fight bacteria and soothe irritation, while the subsalicylate (a compound related to aspirin) aids in reducing inflammation and intestinal discomfort.

The main forms of bismuth subsalicylate include bismuth subsalicylate tablets, bismuth subsalicylate suspension, and bismuth subsalicylate chewable tablets. Bismuth subsalicylate tablets are solid, swallowable tablets containing a specific amount of the compound. It is distributed through various channels such as online pharmacies, retail pharmacies, supermarkets, hypermarkets, and health and wellness stores. This medication is used for gastrointestinal disorders, diarrhea, nausea, heartburn, and indigestion. It is used by a variety of end-users, including adult consumers, pediatric consumers, healthcare professionals, caretakers, and guardians.

The bismuth subsalicylate market research report is one of a series of new reports from The Business Research Company that provides bismuth subsalicylate market statistics, including bismuth subsalicylate industry global market size, regional shares, competitors with a bismuth subsalicylate market share, detailed bismuth subsalicylate market segments, market trends and opportunities, and any further data you may need to thrive in the bismuth subsalicylate industry. This bismuth subsalicylate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bismuth subsalicylate market size has grown strongly in recent years. It will grow from $1.70 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historical period can be attributed to factors such as the rising geriatric population, increased disposable income, growing consumer preference for self-medication, a surge in travel-related gastrointestinal issues, and the increased consumption of processed foods contributing to digestive problems.

The bismuth subsalicylate market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The projected growth during the forecast period is driven by factors including the increasing prevalence of gastrointestinal disorders, rising demand for over-the-counter (OTC) medications, growing awareness of digestive health, the expansion of the pharmaceutical industry, and the development of healthcare infrastructure in emerging markets. Key trends in the forecast period include the popularity of antacid and anti-nausea medications, the availability of bismuth subsalicylate in both liquid and tablet forms, advancements in drug formulations that improve patient compliance, strategic collaborations between pharmaceutical companies, and the development of bismuth subsalicylate-based branded formulations.

The rising prevalence of gastrointestinal disorders is expected to drive the growth of the bismuth subsalicylate market in the coming years. Gastrointestinal disorders affect the digestive tract, including the stomach, intestines, and related organs, and often result in symptoms such as pain, bloating, and changes in bowel movements. Poor dietary habits, such as excessive consumption of processed foods and insufficient fiber intake, are major contributors to the increase in gastrointestinal disorders, as they disrupt the balance of gut microbiota and impair digestion. Bismuth subsalicylate is commonly used to alleviate gastrointestinal issues such as diarrhea by reducing gut inflammation and inhibiting the growth of harmful bacteria. For instance, a report published by ScienceDirect in May 2025 stated that approximately 23.5 million gastrointestinal endoscopies were performed in 2022, marking a 6% increase from the previous year. Consequently, the growing prevalence of gastrointestinal disorders will drive the demand for bismuth subsalicylate.

The growth of the pharmaceutical industry is expected to fuel the expansion of the bismuth subsalicylate market. The pharmaceutical industry focuses on the research, development, manufacturing, and marketing of medications and therapeutic products to improve health and treat various medical conditions. As chronic diseases become more prevalent globally, the demand for innovative treatments continues to rise, prompting further growth in the pharmaceutical sector. This expansion is enhancing the availability of advanced formulations and distribution channels for bismuth subsalicylate, making it more accessible worldwide as a treatment for gastrointestinal disorders. For example, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reported in November 2024 that the pharmaceutical industry contributed $2,295 billion to the global GDP in 2022, with $755 billion from direct contributions, representing 0.7% of global GDP. The continued growth of the pharmaceutical industry is expected to support the development and distribution of bismuth subsalicylate.

Major companies in the bismuth subsalicylate market are innovating new formulations, such as chewable tablets, to improve medication adherence and provide more effective digestive relief. Chewable tablets are designed to be easier to consume and allow for faster absorption compared to traditional tablets. For example, in May 2025, Wonderbelly, a U.S.-based pharmaceutical company, introduced a dye-free alternative to Pepto-Bismol, offering chewable tablets that provide relief from upset stomach, diarrhea, indigestion, and nausea. These tablets contain the same active ingredient-bismuth subsalicylate-but are formulated without dyes or talc, offering a more consumer-friendly option.

Major players in the bismuth subsalicylate market are Procter & Gamble, GlaxoSmithKline Plc, Perrigo Company Plc, Siegfried AG, Laboratorios Imperiales S.A. de C.V., Shandong Xinhua Pharmaceutical Co. Ltd., Alpha Chemika, JQC (Huayin) Pharmaceutical Co. Ltd., Chr. Olesen Group, Vital Materials Co. Ltd., Shanpar Industries Pvt. Ltd., OCB Pharmaceutical, Muby Chemicals, A. B. Enterprises, Samuh Laxmi, Lumax Pharmaceutical Labs Pvt. Ltd., GB Nitrochem Pvt. Ltd., Indian Platinum Private Limited, Organs Bio Lab Private Limited, Maan Medex Private Limited.

North America was the largest region in the bismuth subsalicylate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bismuth subsalicylate report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bismuth subsalicylate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bismuth subsalicylate market consists of sales of stomach relief caplets, travel sickness relief kits, digestive aid strips, and stomach pain relief lozenges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bismuth Subsalicylate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bismuth subsalicylate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bismuth subsalicylate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bismuth subsalicylate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bismuth Subsalicylate Market Characteristics

3. Bismuth Subsalicylate Market Trends And Strategies

4. Bismuth Subsalicylate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bismuth Subsalicylate Growth Analysis And Strategic Analysis Framework

6. Bismuth Subsalicylate Market Segmentation

7. Bismuth Subsalicylate Market Regional And Country Analysis

8. Asia-Pacific Bismuth Subsalicylate Market

9. China Bismuth Subsalicylate Market

10. India Bismuth Subsalicylate Market

11. Japan Bismuth Subsalicylate Market

12. Australia Bismuth Subsalicylate Market

13. Indonesia Bismuth Subsalicylate Market

14. South Korea Bismuth Subsalicylate Market

15. Western Europe Bismuth Subsalicylate Market

16. UK Bismuth Subsalicylate Market

17. Germany Bismuth Subsalicylate Market

18. France Bismuth Subsalicylate Market

19. Italy Bismuth Subsalicylate Market

20. Spain Bismuth Subsalicylate Market

21. Eastern Europe Bismuth Subsalicylate Market

22. Russia Bismuth Subsalicylate Market

23. North America Bismuth Subsalicylate Market

24. USA Bismuth Subsalicylate Market

25. Canada Bismuth Subsalicylate Market

26. South America Bismuth Subsalicylate Market

27. Brazil Bismuth Subsalicylate Market

28. Middle East Bismuth Subsalicylate Market

29. Africa Bismuth Subsalicylate Market

30. Bismuth Subsalicylate Market Competitive Landscape And Company Profiles

31. Bismuth Subsalicylate Market Other Major And Innovative Companies

32. Global Bismuth Subsalicylate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bismuth Subsalicylate Market

34. Recent Developments In The Bismuth Subsalicylate Market

35. Bismuth Subsalicylate Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â